ANKRD6 and melanoma: However, research by Prabhakar et al. revealed that miR-214-3p can also exert an oncogenic role in melanoma by targeting and suppressing two key negative regulators (ANKRD6 or CTBP1) of Wnt signaling, thereby indirectly activating β-catenin pathway [36].